Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
AI662270/GRP94 axis couples the unfolded protein response to mitochondrial dynamics during acute myocardial infarction
Suling Ding, Wen Liu, Zhiwei Zhang, Xiyang Yang, Dili Sun, Jianfu Zhu, Xiaowei Zhu, Shijun Wang, Mengshi Xie, Hongyu Shi, Junbo Ge, Xiangdong Yang
Suling Ding, Wen Liu, Zhiwei Zhang, Xiyang Yang, Dili Sun, Jianfu Zhu, Xiaowei Zhu, Shijun Wang, Mengshi Xie, Hongyu Shi, Junbo Ge, Xiangdong Yang
View: Text | PDF
Research Article Cardiology Cell biology

AI662270/GRP94 axis couples the unfolded protein response to mitochondrial dynamics during acute myocardial infarction

  • Text
  • PDF
Abstract

The unfolded protein response (UPR), triggered by endoplasmic reticulum (ER) stress, comprises distinct pathways orchestrated by conserved molecular sensors. Although several of these components have been suggested to protect cardiomyocytes from ischemic injury, their precise functions and mechanisms remain elusive. In this study, we observed a marked increase in glucose-regulated protein 94 (GRP94) expression at the border zone of cardiac infarct in a mouse model. GRP94 overexpression ameliorated post-infarction myocardial damage and reduced infarct size. Conversely, GRP94 deficiency exacerbated myocardial dysfunction and infarct size. Mechanistically, GRP94 alleviated hypoxia-induced mitochondrial fragmentation, whereas its depletion exacerbated this fragmentation. Molecular investigations revealed that GRP94 specifically facilitated the cleavage of Opa1 into L-Opa1, but not S-Opa1. The study further elucidated that under hypoxic conditions, the binding shift of Yy1 from lncRNA Oip5os1 to AI662270 promoted Yy1’s binding on the GRP94 promoter, thereby enhancing GRP94 expression. AI662270 attenuated mitochondrial over-fragmentation and ischemic injury after myocardial infarction similarly to GRP94. Moreover, coimmunoprecipitation coupled with LC-MS/MS identified the interaction of GRP94 with Anxa2, which regulates Akt1 signaling to maintain L-Opa1 levels. Overall, these findings unveiled what we believe is a novel role for the AI662270/GRP94 axis in linking ER stress to mitochondrial dynamics regulation, proposing new therapeutic avenues for managing cardiovascular conditions through ER stress modulation.

Authors

Suling Ding, Wen Liu, Zhiwei Zhang, Xiyang Yang, Dili Sun, Jianfu Zhu, Xiaowei Zhu, Shijun Wang, Mengshi Xie, Hongyu Shi, Junbo Ge, Xiangdong Yang

×

Figure 7

GRP94 interacts with Anxa2 to regulate the cleavage of Opa1.

Options: View larger image (or click on image) Download as PowerPoint
GRP94 interacts with Anxa2 to regulate the cleavage of Opa1.
(A and B) H...
(A and B) Hypoxia and ER stress remodel GRP94 interactomes. Cardiomyocytes exposed to (A) hypoxia (12 hours) or (B) tunicamycin (TN, 15 mg/L, 12 hours). GRP94 coimmunoprecipitated proteins identified by LC-MS/MS. (C) Anxa2 knockdown (si-Anxa2, 40 nM) blocks GRP94-mediated L-Opa1 stabilization. Cells infected with Ad-GRP94 or Ad-Glb1 (MOI = 50) and transfected with si-Anxa2/si-NC for 36 hours, followed by hypoxia (12 hours). Opa1 isoforms analyzed by immunoblotting (n = 4). (D) Endogenous GRP94-Anxa2 interaction under hypoxia. Co-IP with anti-GRP94 or IgG in hypoxic cardiomyocytes (12 hours). (E) GRP94 overexpression enhances Anxa2 and p-Akt1 levels. Ad-GRP94–infected cells (MOI = 50, 48 hours). Anxa2, p-Akt1 (Ser473), and L-Opa1 analyzed (n = 4). (F) Anxa2 deletion abrogates GRP94-induced p-Akt1 and L-Opa1. Ad-GRP94 (MOI = 50) + si-Anxa2/si-NC (40 nM, 48 hours). Protein levels quantified (n = 4). (G) Akt1 inhibitor LY294002 (50 μM) reverses GRP94 effects. Ad-GRP94–infected cells treated with LY294002 for 48 hours (n = 4). Anxa2, p-Akt1, and Opa1 protein was analyzed by immunoblot (n = 4). (H) Anxa2 knockdown negates GRP94-mediated mitochondrial protection. Mitochondrial morphology was assessed by MitoTracker (≥50 cells/group). Categories: filamentous (>80% tubular), intermediate (30%–80%), fragmented (<30%). Scale bar: 20 μm (n = 4). *P < 0.05; **P < 0.01 versus the indicated group by 2-way ANOVA with Bonferroni’s multiple-comparison test. (I) Anxa2 deletion abolishes the GRP94 antiapoptotic effect. TUNEL assay in cells treated as in F. Scale bar: 50 μm (n = 4). All data are expressed as mean ± SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts